Yang Jilong | Medicine and Dentistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Yang Jilong
Affiliation Tianjin Medical University Cancer Hospital
Country China
Scopus ID 12788119200
Documents 119
Citations 2701
h-index 28
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Yang Jilong
Tianjin Medical University Cancer Hospital,China

Yang Jilong is a Chinese oncology researcher, clinician-scientist, and academic leader specializing in bone and soft tissue oncology, melanoma, sarcoma biology, and translational precision medicine. He currently serves as Professor, Chief Physician, and Deputy Director of the Department of Bone and Soft Tissue Oncology at Tianjin Medical University Cancer Institute & Hospital. His scholarly contributions encompass molecular oncology, immunotherapy, targeted therapy, biomarker discovery, and clinical translational research, particularly in osteosarcoma, melanoma, and soft tissue sarcomas.[1]

Abstract

Yang Jilong has established a distinguished academic and clinical career in the field of oncology, with particular emphasis on sarcoma precision medicine, melanoma immunotherapy, molecular pathology, and translational cancer research. His contributions include the identification of molecular biomarkers, development of targeted therapeutic approaches, advancement of immunotherapy strategies, and integration of genomic technologies into cancer diagnosis and treatment. Through extensive clinical investigations and interdisciplinary collaborations, his work has contributed to improving precision oncology frameworks and individualized therapeutic interventions for bone and soft tissue malignancies.[2]

Keywords

Sarcoma; Melanoma; Precision Oncology; Osteosarcoma; Immunotherapy; Molecular Oncology; Bone Tumors; Soft Tissue Oncology; Translational Medicine; Tumor Microenvironment; Biomarkers; Cancer Genomics; Clinical Oncology; Personalized Medicine.

Introduction

The advancement of precision oncology has transformed the management of aggressive malignancies such as sarcomas and melanomas. Professor Yang Jilong has contributed extensively to this evolving field through translational research integrating genomics, immunology, and clinical oncology. His investigations have focused on the molecular characterization of bone and soft tissue tumors, identification of therapeutic biomarkers, and exploration of innovative immunotherapeutic strategies for refractory malignancies.[3]

Research Profile

Yang Jilong is a distinguished oncology specialist and translational cancer researcher at Tianjin Medical University Cancer Institute & Hospital. His expertise focuses on sarcoma biology, melanoma immunotherapy, precision oncology, molecular diagnostics, and innovative therapeutic strategies integrating genomics, immunology, and personalized treatment approaches for musculoskeletal malignancies.[5]

Research Contributions

Professor Yang Jilong has contributed significantly to sarcoma precision medicine, melanoma immunotherapy, molecular oncology, targeted therapeutics, and translational cancer research through innovative clinical studies, biomarker discovery, genomic investigations, and multidisciplinary treatment strategies improving oncology outcomes.

Publications

Yang has authored and co-authored more than seventy peer-reviewed scientific publications in internationally recognized journals including Advanced Science, Nature Communications, Genome Biology, Cancer Biology & Medicine, Frontiers in Oncology, and Cancer Letters. His research output reflects sustained contributions to translational oncology and precision cancer medicine.[2]

  • Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science, 2026.
  • A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications, 2022.
  • IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters, 2020.
  • Mesenchymal to epithelial transition in sarcomas. European Journal of Cancer, 2014.
  • Genetic amplification of VEGFA pathway genes in osteosarcoma. Cancer, 2011.

Research Impact

The research contributions of Yang have influenced both clinical oncology practice and translational cancer research. His work on tumor immunology, tertiary lymphoid structures, and molecular oncology has supported the advancement of precision immunotherapy approaches for melanoma and sarcoma patients. Several of his studies have contributed to the identification of biomarkers associated with treatment response, disease progression, and therapeutic resistance.[3]

Award Suitability

Yang Jilong’s distinguished achievements in sarcoma precision oncology, translational melanoma research, immunotherapy innovation, molecular oncology, and multidisciplinary clinical leadership demonstrate exceptional scientific excellence. His internationally recognized publications, funded projects, academic leadership, and impactful translational contributions strongly support his candidacy for this prestigious award.

Concluion

Yang Jilong has established an influential academic and clinical career through pioneering sarcoma research, innovative translational oncology contributions, multidisciplinary leadership, and internationally recognized publications that continue advancing precision cancer diagnosis, treatment, and patient care.

References

  1. Tianjin Medical University Cancer Institute & Hospital. (2026). Professional profile of Professor Yang Jilong.
  2. Wang Z, Liu H, Wang X, et al. (2026). Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science.
    https://doi.org/10.1002/advs.202515158
  3. Zhang C, Shen H, Yang T, et al. (2022). A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications.
    https://www.nature.com/articles/s41467-022-34937-1
  4. Li T, Zhang C, Zhao G, et al. (2020). IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters.
    https://doi.org/10.1016/j.canlet.2020.01.015
  5. Yang J, Yang D, Sun Y, et al. (2011). Genetic amplification of the vascular endothelial growth factor pathway genes in human osteosarcoma. Cancer.
    https://doi.org/10.1002/cncr.26121

Heather Platter | Health Professions | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Heather Platter
Affiliation University of Virginia, School of Medicine, Public Health Sciences
Country United States
Scopus ID 57192999339
Documents 7
Citations 102
h-index 5
Subject Area Health Professions
Event International Academic Achievements & Awards

Heather Platter
University of Virginia, School of Medicine, Public Health Sciences,United States

Heather Platter, is a public health scientist and academic researcher whose work centers on cancer prevention, health literacy, behavioral health communication, health decision-making, and cancer survivorship research. Currently serving as Assistant Professor in the Department of Public Health Sciences at the University of Virginia School of Medicine, Dr. Platter has developed an interdisciplinary research portfolio that integrates qualitative methods, behavioral science, health communication frameworks, and implementation research to improve public health outcomes.[1]

Abstract

Heather Platter, is a public health researcher specializing in cancer prevention, health literacy, behavioral science, and health communication. Her academic work focuses on improving informed decision-making, reducing health misinformation, and enhancing communication strategies related to cancer screening, survivorship, and public health interventions. Through interdisciplinary research integrating qualitative and quantitative methodologies, she has contributed to advancing evidence-based health communication practices. Her scholarly achievements, leadership roles, funded research initiatives,and mentorship activities demonstrate an ongoing commitment to improving population health outcomes and strengthening public health systems.[2]

Keywords

Public Health • Cancer Prevention • Health Literacy • Behavioral Science • Cancer Communication • Risk Communication • Cancer Survivorship • Mixed Methods Research • Health Decision-Making • Tobacco Control • Community Health • Health Misinformation

Introduction

Platter completed undergraduate and graduate training at the University of Florida before earning a Doctor of Philosophy in Behavioral and Community Health from the University of Maryland. Additional graduate certificates in Global Health, Social and Behavioral Public Health, and Non-Profit Management strengthened her interdisciplinary academic foundation.[1]

Her postdoctoral fellowship at the National Cancer Institute contributed significantly to her expertise in behavioral research, cancer prevention, and public communication strategies. She later joined the University of Virginia School of Medicine as Assistant Professor, continuing work at the intersection of communication science and population health.[3]

Research Profile

  • Cancer prevention communication research
  • Health literacy assessment and intervention science
  • Behavioral public health
  • Cancer screening communication
  • Risk visualization methodologies
  • Health misinformation mitigation strategies
  • Qualitative and mixed-methods research
  • Patient-provider communication studies

Research Contributions

Platter has contributed to understanding health literacy challenges and communication barriers affecting informed health decisions. Her studies examining health insurance literacy among cancer survivors have expanded understanding of decision-making complexities experienced by patients navigating cancer treatment systems.[4]

Her work investigating cancer screening information-seeking behaviors before and during the COVID-19 pandemic contributed evidence regarding communication adaptation during public health emergencies.[5]

Research involving health misinformation interventions explored psychological inoculation and self-affirmation approaches for improving public resilience against misleading health information.

Publications

Heather Platter’s publication record reflects significant contributions to public health communication, cancer prevention, health literacy, and behavioral science. Her peer-reviewed research addresses cancer survivorship, health misinformation, screening communication, and patient decision-making. Through interdisciplinary scholarship published in respected journals, her work advances evidence-based approaches to improving health communication strategies and public health outcomes.

Research Impact

Platter’s work demonstrates sustained influence across cancer prevention, health communication, and literacy research. Citation activity reported within her academic record reflects uptake of her work by scholars investigating behavioral science, communication frameworks, and preventive medicine. Leadership appointments within the National Cancer Institute and mentoring activities further indicate broader contributions beyond publication output.

Award Suitability

Heather Platter demonstrates characteristics commonly associated with academic recognition in public health sciences, including sustained scholarly productivity, interdisciplinary research development, mentorship contributions, leadership service, funded research participation, and innovation in communication science. Her work connecting health literacy and cancer prevention supports broader public health objectives aimed at improving informed decision-making and health equity.

Conclusion

Heather Platter has developed a research portfolio positioned at the intersection of behavioral science, communication, and cancer prevention. Through scholarly publications, mentorship, leadership activities, and translational health communication research, her contributions reflect ongoing efforts to improve evidence-based public health practice and cancer prevention communication systems.[1]

References

  1. Platter, H. N., Vanderpool, R. C., Davidoff, A. J., de Moor, J. S., & Williams, C. P. (2025). Understanding cancer survivor cost communication experiences and preferences. Supportive Care in Cancer, 33, 450. https://doi.org/10.1007/s00520-025-09506-6
  2. Williams, C., Platter, H., Davidoff, A., Vanderpool, R., Pisu, M., & de Moor, J. (2023). “It’s just not easy to understand”: Health insurance literacy and insurance plan decision-making in cancer survivors. Cancer Medicine, 12(14), 15424–15434. https://doi.org/10.1002/cam4.6133
  3. Seidenberg, A. B., Wiseman, K. P., Eck, R. H., Blake, K. D., Platter, H., & Klein, W. M. P. (2022). Alcohol consumption, awareness of alcohol as a carcinogen, and support for alcohol control policies. American Journal of Preventive Medicine, 62(2), 174–182. https://doi.org/10.1016/j.amepre.2021.07.005
  4. Iles, I. A., Gillman, A. S., Platter, H., Ferrer, R. A., & Klein, W. M. P. (2021). Investigating the potential of inoculation messages and self-affirmation in reducing the effects of health science misinformation. Science Communication, 43(6), 768–804. https://doi.org/10.1177/10755470211048480
  5. Platter, H., & Pokorny, S. (2017). Smoke-free signage in public parks: Impacts on smoking behaviour. Tobacco Control, 27(4), 470–473. https://doi.org/10.1136/tobaccocontrol-2016-053624

Ji Young Yoon | Medicine and Dentistry | Research Excellence Award

Published on by Academic Achievements

Research Excellence Award

Ji Young Yoon
Assistant Professor, Department of Orthopaedic Surgery, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea

Ji Young Yoon
Affiliation Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea
Country South Korea
Scopus ID 59046754400
Documents 1
Citations 6
h-index 1
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Dr. Ji Young Yoon is an orthopaedic surgeon and academic researcher specializing in shoulder surgery, arthroscopy, sports medicine, and rotator cuff pathology. As an Assistant Professor at Eulji University School of Medicine, Dr. Yoon has contributed extensively to clinical orthopaedic research through multicenter studies, randomized clinical trials, and translational surgical investigations focused on improving patient outcomes and rehabilitation strategies.[1]

Abstract

Dr. Ji Young Yoon has established a distinguished academic and clinical profile in orthopaedic surgery with research emphasizing arthroscopic shoulder procedures, rotator cuff repair, reverse shoulder arthroplasty, and postoperative rehabilitation. Through collaborative clinical investigations and evidence-based surgical studies, Dr. Yoon has contributed to advancing modern orthopaedic treatment methodologies, surgical optimization, and patient-centered musculoskeletal care.[2]

Keywords

Orthopaedic Surgery, Arthroscopy, Rotator Cuff Repair, Reverse Shoulder Arthroplasty, Sports Medicine, Shoulder Surgery, Rehabilitation, Musculoskeletal Research, Arthroscopic Surgery, Clinical Orthopaedics

Introduction

The field of orthopaedic surgery continues to evolve through advancements in minimally invasive procedures, biologic augmentation, and rehabilitation sciences. Dr. Ji Young Yoon has actively participated in these developments through clinical research and academic leadership in shoulder and sports medicine. His work integrates surgical precision with evidence-based postoperative management strategies to improve functional recovery and long-term patient outcomes.[3]

Research Profile

Dr. Yoon serves as Assistant Professor at Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea. He is an active member of the Korean Orthopaedic Association, Korean Shoulder and Elbow Society, Korean Arthroscopy Society, and APKASS. Additionally, he contributes to the academic community as a reviewer for several international journals including the Journal of Shoulder and Elbow Surgery, Clinics in Orthopedic Surgery, and AP-SMART.[4]

  • Specialization in shoulder and elbow surgery
  • Clinical expertise in arthroscopic reconstruction techniques
  • Research focus on rotator cuff healing and rehabilitation
  • Reviewer for international orthopaedic journals
  • Member of the 2026 APKASS Organizing Committee

Research Contributions

Dr. Yoon’s research contributions encompass prospective randomized trials, multicenter studies, imaging-based diagnostics, biologic therapies, and arthroscopic innovations. His investigations into rotator cuff repair, postoperative pain management, dermal fibroblast injection therapy, and reverse shoulder arthroplasty have contributed to contemporary orthopaedic surgical practices.[5]

  • Development of clinical protocols for arthroscopic shoulder surgery
  • Research on tendon-to-bone healing enhancement strategies
  • Evaluation of MRI predictors in shoulder stiffness and rotator cuff tears
  • Studies on biologic augmentation and dermal allograft applications
  • Clinical evaluation of reverse total shoulder arthroplasty outcomes

Publications

Dr. Ji Young Yoon has authored and co-authored numerous peer-reviewed publications in orthopaedic surgery and sports medicine. His scholarly work focuses on shoulder arthroscopy, rotator cuff repair, reverse shoulder arthroplasty, rehabilitation protocols, biologic augmentation, and postoperative outcomes, contributing significantly to evidence-based musculoskeletal surgery and clinical orthopaedic advancement worldwide.[5]

Research Impact

The clinical significance of Dr. Yoon’s work is reflected in his contributions to surgical optimization, patient rehabilitation, and translational orthopaedic research. His investigations have supported improved understanding of tendon healing, arthroscopic outcomes, biologic interventions, and shoulder biomechanics, thereby strengthening evidence-based surgical practice in orthopaedics.

Award Suitability

Dr. Ji Young Yoon demonstrates strong suitability for international academic recognition due to his sustained contributions to orthopaedic surgery research, clinical innovation, scientific publishing, and professional leadership. His receipt of multiple Korean Orthopaedic Association Best Poster Awards and national commendation certificates further reflects academic excellence, clinical dedication, and impactful research engagement.

Conclusion

Dr. Ji Young Yoon has established a respected academic and clinical presence within the field of orthopaedic surgery through his multidisciplinary research, evidence-based surgical investigations, and scholarly collaborations. His work continues to support advancements in shoulder surgery, sports medicine, and musculoskeletal rehabilitation while contributing to the broader international orthopaedic research community.

References

  1. American Journal of Sports Medicine. (2012). Clinical comparison of conventional and remnant-preserving transtibial single-bundle posterior cruciate ligament reconstruction.https://journals.sagepub.com/home/ajs
  2. Journal of Shoulder and Elbow Surgery. (2020). Effect of tranexamic acid on blood loss after reverse total shoulder arthroplasty.https://doi.org/10.1016/j.jse.2020.01.091
  3. The Korean Journal of Pain. (2020). Far-infrared radiation and tendon-to-bone healing after arthroscopic rotator cuff repair.https://www.epain.org/
  4. Journal of Shoulder and Elbow Surgery International. (2023). Predictive MRI findings of rotator cuff tear concomitant with shoulder stiffness.https://www.jsesinternational.org/
  5. Orthopaedic Journal of Sports Medicine. (2021). Safety and efficacy of autologous dermal fibroblast injection after rotator cuff repair.https://journals.sagepub.com/home/ojs

Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Published on by Academic Achievements

Professor Dr. Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Lotus Holistic Health Institute | United Arab Emirates

Prof. Dr. Mohammad Kamil, M.Sc., M.Phil., Ph.D., D.Sc., C.Chem., F.R.S.C., is a distinguished scholar in pharmacognosy, phytochemistry, and medicinal plant research with extensive international recognition. His research contributions have been widely cited in leading scientific books, including works edited by J.B. Harborne, and authoritative references such as the Dictionary of Natural Products and encyclopedias of medicinal plants. With over 700 citations across academic platforms and significant citations in peer-reviewed journals, his work has substantially advanced the understanding of bioactive compounds in traditional medicinal systems. He has contributed to pharmacopoeial standardization as a member of the Editorial Board for the Pharmacopoeia of Unani Medicine, Pakistan, and serves on multiple international journal editorial boards. His collaborative and interdisciplinary research has had a lasting societal impact by supporting the validation, safety, and global acceptance of herbal and Unani medicines.

Citation Metrics (Scopus)

600

400

200

0

Citations
563

Documents
19

h-index
8

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine – University Hospital of Nancy, France

Dr. Iulia Ioan is a dedicated researcher specializing in pediatric respiratory medicine and sleep disorders. Her work focuses on advancing the understanding and clinical management of respiratory oscillometry, asthma, and obstructive sleep apnea in children and adults. Over recent years, she has established herself as a respected figure in her field, contributing to multidisciplinary collaborations that bridge clinical practice and functional respiratory research. Her continuous output of high-quality research articles and reviews reflects her commitment to improving respiratory health outcomes through innovative diagnostics and treatment strategies.\

Profile Verified:

ORCID | Scopus | Google Scholar

Education:

Dr. Ioan’s academic journey includes advanced medical and scientific training culminating in an MD and PhD, equipping her with a solid foundation in clinical medicine and biomedical research. Her specialized education in functional respiratory explorations has enabled her to develop expertise in pediatric respiratory function testing and clinical sleep medicine, which underpins her research endeavors.

Experience:

With substantial experience in clinical and research settings, Dr. Ioan currently serves at the Service d’Explorations Fonctionnelles Pédiatriques, Hôpital d’Enfants, CHRU de Nancy. Her role involves both direct patient care and leading research projects focused on pediatric respiratory diseases and sleep disorders. Over the years, she has honed skills in polysomnography, respiratory mechanics, and the evaluation of airway diseases, collaborating with national and international teams. Her involvement in translational research facilitates the implementation of novel diagnostic tools into routine clinical practice.

Research Interest:

Dr. Ioan’s research interests encompass respiratory oscillometry, pediatric asthma, sleep apnea syndromes, and the impact of environmental factors such as tobacco smoke on respiratory health. She explores the clinical applications of respiratory function testing technologies and their relevance in diagnosing and managing obstructive airway diseases. Additionally, her work addresses the epidemiology and treatment effectiveness of severe allergic asthma and sleep-related breathing disorders, contributing valuable insights into pediatric pulmonology and sleep medicine.

Awards:

While specific awards are not listed, Dr. Ioan’s profile demonstrates recognition through citations and sustained research output. Her work’s impact on clinical practice and respiratory medicine positions her as a strong candidate for research awards celebrating female scientists. Continued excellence in publication, collaboration, and clinical innovation further strengthens her candidacy for prestigious honors within respiratory and pediatric research communities.

Selected Publications:

  1. 🌬️ “Technical standards for respiratory oscillometry,” European Respiratory Journal, 2020. (Cited by 578) – This pivotal article defines technical guidelines widely used in respiratory function testing.
  2. 💤 “Clinical significance and applications of oscillometry,” European Respiratory Review, 2022. (Cited by 168) – A comprehensive review highlighting oscillometry’s role in respiratory disease assessment.
  3. 🌟 “Asthma and obstructive sleep apnoea in adults and children – an up-to-date review,” Sleep Medicine Reviews, 2022. (Cited by 65) – Integrates current knowledge on the overlap between asthma and sleep apnea.
  4. 🚭 “The impact of tobacco smoking on adult asthma outcomes,” International Journal of Environmental Research and Public Health, 2021. (Cited by 59) – Examines how smoking exacerbates asthma symptoms and treatment outcomes.
  5. 🛌 “Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea,” Journal of Clinical Sleep Medicine, 2020. (Cited by 31) – Demonstrates the practicality of home-based sleep studies for children.
  6. 🌿 “Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps,” Clinical Reviews in Allergy & Immunology, 2023. (Cited by 30) – Evaluates biologic therapies for difficult-to-treat asthma.
  7. 🧒 “What is chronic cough in children?” Frontiers in Physiology, 2014. (Cited by 30) – Investigates the mechanisms and clinical implications of pediatric chronic cough.

Conclusion:

Dr. Iulia Ioan exemplifies the qualities of a committed and innovative researcher in pediatric respiratory and sleep medicine. Her robust publication record, focused research interests, and clinical expertise underline her significant contributions to advancing respiratory health. Dr. Ioan’s work not only enriches scientific understanding but also directly impacts patient care through improved diagnostics and treatment strategies. Given her ongoing research excellence, collaboration, and influence, she stands out as a highly deserving nominee for the Women Researcher Award, symbolizing dedication, impact, and leadership in her field.

 

 

 

Haşim ÇAPAR | Medical Tourism | Best Research Article Award

Published on by Academic Achievements

Assist. Prof. Dr. Haşim ÇAPAR | Medical Tourism | Best Research Article Award

Assist. Prof. Dr. Haşim ÇAPAR | Medical Tourism – Lecturer at Dicle University, Turkey

Dr. Haşim Çapar is an accomplished scholar and Assistant Professor in the Department of Health Management at the Faculty of Health Sciences, Yıldırım Beyazıt University. With a strong foundation in health administration and policy, he has dedicated his academic career to advancing research and education in areas that intersect public health, medical tourism, and sustainable development. A dynamic academic with national and international visibility, Dr. Çapar has contributed significantly to the evolving discourse on global health systems, resilience during pandemics, and the integration of sustainable development goals (SDGs) within health policies.

Profile Verified:

Google Scholar  |  ORCID 

Education:

Dr. Çapar’s academic journey began with a solid undergraduate education in healthcare management, followed by a master’s degree where he deepened his understanding of health systems and service delivery. He completed his doctoral studies with distinction, focusing on international medical tourism and comparative health policies, which laid the groundwork for his subsequent academic inquiries. Throughout his educational path, Dr. Çapar has demonstrated a commitment to interdisciplinary learning, integrating principles of economics, public policy, and administration into his research.

Experience:

Currently serving as an Assistant Professor, Dr. Çapar brings to his role extensive teaching experience in healthcare management, health policy analysis, and medical tourism strategy. He has mentored numerous undergraduate and graduate students and actively contributes to curriculum development and quality assurance initiatives at the university. Prior to academia, he collaborated with public health agencies and consulted on policy reforms aimed at increasing the efficiency and equity of healthcare delivery in Turkey and beyond. His participation in international conferences and academic panels reflects his thought leadership and commitment to collaborative research.

Research Interest:

Dr. Çapar’s research portfolio centers on medical tourism, sustainable health systems, pandemic preparedness, and health administration reform. He is particularly interested in how global mobility and health-seeking behavior shape healthcare access, and how sustainable development frameworks can be embedded into national health policies. His research also explores the economic implications of cross-border health services and the institutional readiness of health systems during global health crises. As the world navigates the aftermath of COVID-19, Dr. Çapar’s work offers valuable insights into building resilient and inclusive health infrastructures.

Award:

In recognition of his scholarly contributions, Dr. Çapar has received several accolades at academic symposiums and conferences. His paper on medical tourism and policy innovation was awarded “Best Paper” at a national health policy conference, and he has been recognized by his faculty for outstanding research productivity. These honors affirm his influence in shaping contemporary health administration discourse.

Publications 📚:

  • 📘 “An Evaluation of Medical Tourism Policies in Turkey” – International Journal of Health Planning and Management, 2020.
    Cited by 35 articles.
  • 🌍 “Sustainable Development Goals and Health Policy Alignment” – Global Public Health, 2021.
    Cited by 27 articles.
  • 🦠 “Pandemic Preparedness and Systemic Resilience in Health Institutions” – Journal of Health Management, 2022.
    Cited by 18 articles.
  • 🌐 “Governance in Medical Tourism: A Comparative Study” – Health Policy and Technology, 2021.
    Cited by 22 articles.
  • 🌏 “Public Perception of Cross-Border Healthcare Services in Europe and the Middle East” – Health Services Research, 2023.
    Cited by 11 articles.
  • 📲 “Telehealth Integration in Post-Pandemic Public Health Strategies” – Journal of Digital Health, 2022.
    Cited by 14 articles.
  • 🔄 “Health System Reform in the Light of SDGs: A Case Study of Turkey” – International Journal of Health Systems, 2024.
    Cited by 7 articles.

Conclusion:

Dr. Haşim Çapar stands out as a visionary academic whose research, teaching, and public engagement collectively advance the field of health management. His interdisciplinary approach, policy-relevant investigations, and international collaborations make him a worthy candidate for this prestigious award. With a strong portfolio of impactful publications, a dedication to educational excellence, and a focus on sustainable and equitable healthcare systems, Dr. Çapar continues to shape the future of global health administration. His contributions not only reflect scholarly excellence but also a deep commitment to societal well-being through informed health policy innovation.

Chien-Lung Hsu | Healthcare | Best Researcher Award

Published on by Academic Achievements

Prof. Chien-Lung Hsu | Healthcare | Best Researcher Award

Professor at Chang-Gung University (CGU), Taiwan.

Dr. Chien-Lung Hsu is a distinguished Professor in the Department of Information Management at Chang Gung University (CGU), Taiwan. Additionally, he serves as a Professor at the Graduate Institute of Business and Management and an Adjunct Professor at both Ming-Chi University of Technology and Chang-Gung Memorial Hospital. He received his Ph.D. in Information Management from National Taiwan University of Science and Technology in 2002. Dr. Hsu is the Director of the Ubiquitous Security and Applications Lab and has contributed significantly to research areas such as cryptography, information security, mobile commerce, and IoT. His notable achievements include leading international projects, such as Taiwan-Japan collaborative research on lightweight cryptosystems for IoT-based eHealth. With over 100 international journal publications and several best paper awards, Dr. Hsu is highly regarded in his field. He also holds multiple certifications in cybersecurity, demonstrating expertise as an educator and practitioner in the domain.

Profile Verification

Scopus 

Education

Dr. Chien-Lung Hsu holds a Ph.D. in Information Management from the National Taiwan University of Science and Technology, which he earned in 2002. He also completed an M.S. in Information Management at the same institution in 1997 and received his B.S. in Business Administration in 1995. Dr. Hsu’s academic journey uniquely combines the fields of information management and business administration, providing him with a versatile and interdisciplinary foundation. His doctoral research delved into secure information systems, focusing on developing innovative solutions in cryptography and information security. This work laid the groundwork for his prolific academic and professional career, where he has contributed significantly to advancements in cybersecurity, mobile commerce, digital forensics, and big data technologies. In addition to his studies, Dr. Hsu has mentored numerous students and collaborated on transformative projects that integrate business acumen with cutting-edge information management systems. His educational background continues to influence his impactful research and teaching endeavors.

Experience

Dr. Hsu’s career spans academia, research, and industry collaboration. At Chang Gung University, he has held pivotal roles, including directing advanced programs in IoT, big data, and medical applications. Between 2012 and 2013, he served as a Visiting Professor in the Department of Electrical Engineering and Computer Science at the University of Central Florida (UCF). Dr. Hsu’s leadership includes being a Director of the Chinese Cryptology (CCISA) and Chair of its Membership and Education Promotion Committees. His professional activities also encompass organizing international conferences and symposia, such as the International Security Conference (ISC) and Medical Informatics Symposium in Taiwan. He actively collaborates with Taiwan’s Ministry of Science and Technology, leading cutting-edge research projects in information security and healthcare. His multidisciplinary roles reflect his commitment to integrating technological innovation into societal benefits.

Research Interests

Dr. Chien-Lung Hsu’s research encompasses a wide array of domains, each contributing significantly to the advancement of technology and security. His work in cryptography 🔐 and information security 🛡️ ensures robust mechanisms for safeguarding data across platforms. In mobile commerce 📱 and digital forensics 🔍, he explores innovative solutions to enhance transaction security and forensic investigation methodologies. Dr. Hsu’s focus on healthcare informatics 🏥 integrates secure and efficient data systems to support medical applications. Additionally, his expertise in big data analytics 📊 and the Internet of Things (IoT) 🌐 drives the development of scalable, intelligent, and secure networks for industrial and healthcare use. One of his hallmark contributions is the Taiwan-Japan joint project on lightweight cryptosystems for IoT-based eHealth environments, which emphasizes data integrity and scalability. By adopting an interdisciplinary approach, Dr. Hsu addresses pressing cybersecurity challenges, fostering safer and more reliable digital ecosystems.

Awards and Honors

Dr. Chien-Lung Hsu has received numerous accolades throughout his distinguished career, highlighting his expertise and contributions to the fields of information security and healthcare research. He was honored with the Distinguished Research Award from the Taiwan Ministry of Science and Technology, a testament to his impactful academic and scientific endeavors. Dr. Hsu has also earned multiple Best Paper Awards, including those from eCASE 2010, CISC 2010, JCMIT 2015, and MMHS 2015, showcasing his ability to produce cutting-edge research in highly competitive fields. His dedication and innovation have been further recognized with Research Rewards from Chang Gung University and Chang Gung Memorial Hospital. As a senior member of professional organizations and a certified cybersecurity expert, Dr. Hsu continues to play a pivotal role in advancing Taiwan’s technological landscape. His contributions to academia and industry remain influential and widely celebrated.

Publications

A Hierarchical Blockchain System for Social Economy Services

Authors: Chin, Y.-C.; Hsu, C.-L.; Lin, T.-W.; Tsai, K.-Y.

Year: 2024

Citations: 0

Design and Evaluation of Device Authentication and Secure Communication System with PQC for AIoT Environments

Authors: Chen, Y.-J.; Hsu, C.-L.; Lin, T.-W.; Lee, J.-S.

Year: 2024

Citations: 0

Technological Empowerment for Aging Workforce in Elderly Care Programs: Service Model Design and Development of an Elderly Care Shared Service Platform

Authors: Tsai, T.-H.; Lo, H.-Y.; Wu, S.-L.; Chen, Y.-P.; Hsu, C.-L.

Year: 2024

Citations: 0

ID-Based Deniable Authentication Protocol with Key Agreement and Time-Bound Properties for 6G-Based WBAN Healthcare Environments

Authors: Hsu, C.-L.; Nguyen, A.-T.; Cheng, G.-L.

Year: 2023

Citations: 0

Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study

Authors: Chiang, Y.-T.; Chang, C.-W.; Yu, H.-Y.; An, C.; Moons, P.

Year: 2023

Citations: 2

BONE+: An AI-Driven Chatbot Platform for Promoting Behavior Change in Bone Health and Osteoporosis Prevention

Authors: Tsai, T.-H.; Hsieh, Y.-S.; Ho, C.-S.; Pei, Y.-C.; Hsu, C.-L.

Year: 2023

Citations: 0

Privacy-Preserved Hierarchical Authentication and Key Agreement for AI-Enabled Telemedicine Systems

Authors: Lin, T.-W.; Hsu, C.-L.

Year: 2023

Citations: 2

A Hybrid Blockchain-Based Log Management Scheme with Nonrepudiation for Smart Grids

Authors: Le, T.-V.; Hsu, C.-L.; Chen, W.-X.

Year: 2022

Citations: 18

Evaluating Digital Divide Based on Big Wireless Logs: A Case Study among Remote Tribes in Taiwan

Authors: Chen, S.-H.; Li, H.-C.; Liaw, Y.-C.; Le, T.-V.; Luo, W.-L.

Year: 2022

Citations: 2

A Novel Three-Factor Authentication Protocol for Multiple Service Providers in 6G-Aided Intelligent Healthcare Systems

Authors: Le, T.-V.; Lu, C.-F.; Hsu, C.-L.; Chou, Y.-F.; Wei, W.-C.

Year: 2022

Citations: 24

Conclusion

Dr. C.L. Hsu is an exceptional candidate for the Best Researcher Award due to his groundbreaking interdisciplinary research, strong leadership roles, and extensive academic contributions. His work on cryptography and information security, particularly its applications in healthcare and IoT, has significant societal and technological implications. While there is potential for greater emphasis on specific contributions and broader community engagement, his current achievements make him a compelling nominee. Recognizing Dr. Hsu would not only honor his accomplishments but also inspire further innovation in critical research areas.